Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics
Diagnostics · 25.04.2024 · 14 (9) · 893
DOI: 10.3390/diagnostics14090893 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.04.2024. Verfasst von Constanza Bravo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Clínico Universidad de Chile-OAIC.
Abstract (Originalsprache)
Standard troponin has long been pivotal in diagnosing coronary syndrome, especially Non-ST-Segment Elevation Myocardial Infarction (NSTEMI). The recent introduction of high-sensitivity troponin (hs-cTnI) has elevated it to the gold standard. Yet, its nuanced role in predicting angiographic lesions and clinical outcomes, notably in specific populations like obesity, remains underexplored.
Aim
To evaluate the association between hs-cTnI magnitude in NSTEMI patients and angiographic findings, progression to acute heart failure, and its performance in obesity.
Methods
Retrospective study of 208 NSTEMI patients at a large university center (2020–2023). Hs-cTnI values were assessed for angiographic severity, acute heart failure, and characteristics in the obese population. Data collected and diagnostic performance were evaluated using manufacturer-specified cutoffs.
Results
97.12% of patients had a single culprit vessel. Hs-cTnI elevation correlated with angiographic stenosis severity. Performance for detecting severe coronary disease was low, with no improvement using a higher cutoff. No association was found between hs-cTnI and the culprit vessel location. Hs-cTnI did not predict acute heart failure progression. In the obese population, hs-cTnI levels were higher, but acute heart failure occurred less frequently than in non-obese counterparts.
Conclusions
In NSTEMI, hs-cTnI elevation is associated with significant stenosis, but not with location or acute heart failure. Obesity correlates with higher hs-cTnI levels but a reduced risk of acute heart failure during NSTEMI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Department, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
- Faculty of Medicine, School of Medicine, Universidad de Chile, Santiago 8380456, Chile.
- Cardiovascular Research Unit, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
ORCID-Profile: Alfredo Parra-Lucares
Förderung
- Hospital Clínico Universidad de Chile-OAIC
Zitieren
APA
Bravo, C., Vizcarra, G., Sánchez, A., Cárdenas, F., Canales, J. P., Ugalde, H., & Parra-Lucares, A. (2024). Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics. Diagnostics, 14(9), 893. https://doi.org/10.3390/diagnostics14090893
Vancouver
Bravo C, Vizcarra G, Sánchez A, Cárdenas F, Canales JP, Ugalde H, et al. Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics. Diagnostics. 2024;14(9):893. doi:10.3390/diagnostics14090893
BibTeX
@article{Bravo2024,
author = {Bravo, Constanza and Vizcarra, Geovanna and Sánchez, Antonia and Cárdenas, Francisca and Canales, Juan Pablo and Ugalde, Héctor and Parra-Lucares, Alfredo},
title = {Clinical Implications of High-Sensitivity Troponin Elevation Levels in Non-ST-Segment Elevation Myocardial Infarction Patients: Beyond Diagnostics},
journal = {Diagnostics},
year = {2024},
volume = {14},
number = {9},
pages = {893},
doi = {10.3390/diagnostics14090893}
}
EUVIMED